-
Member
Its been a while since anyone posted on this - stock now down signicantly on October 04 prices - yet promise is still there following April 6 announcement that pre clinical diabetic trial for safety and efficacy using DiaBCell (encapsulated living islet cells) which were transplanted into monkeys wnet off well.
Do I or don't I buy in to this at 32 cents? Wife and daughter both type 1 diabetics and want to believe that LCT can make a difference but in things to do with money musn't let heart rule head.
Anyone out there have an opinion?
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks